446287-01-0 Usage
Uses
Used in Pharmaceutical Industry:
2-BROMO-5-(2-DIETHYLAMINOETHOXY)PYRAZINE is used as a building block for the synthesis of drugs, leveraging its unique structure to contribute to the development of new chemical entities with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-BROMO-5-(2-DIETHYLAMINOETHOXY)PYRAZINE serves as a precursor in the creation of herbicides and insecticides, where its properties are harnessed to enhance the effectiveness of these agricultural chemicals.
Safety Note:
It is crucial to handle 2-BROMO-5-(2-DIETHYLAMINOETHOXY)PYRAZINE with caution due to its potentially hazardous nature. It should be manipulated in controlled laboratory settings, employing appropriate safety measures to ensure the well-being of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 446287-01-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,6,2,8 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 446287-01:
(8*4)+(7*4)+(6*6)+(5*2)+(4*8)+(3*7)+(2*0)+(1*1)=160
160 % 10 = 0
So 446287-01-0 is a valid CAS Registry Number.
446287-01-0Relevant academic research and scientific papers
HETEROARYL-CARBOXYLIC ACIDS AS HISTONE DEMETHYLASE INHIBITORS
-
Page/Page column 86; 87, (2018/01/17)
The invention relates to heteroaryl-carboxylic acids as described herein, useful as histone demethylase inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy, including e.g., in the treatment of cancer.
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
-
Page 119, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
